Buprenorphine is a highly effective treatment for heroin addiction which was recently approved for use in the United States. It is the first opioid that can be prescribed by physicians in the U.S. since the passage of the Harrison Narcotic Act in 1914. French physicians have more than five years experience treating patients with this medication. The widespread use of buprenorphine in France has led to a dramatic nation-wide reduction in heroin overdose deaths and in other harms associated with addiction. Our speakers, three French physicians who conduct research and oversee clinical services, will report on their experiences with this treatment. A discussion following the presentation will highlight differences between U.S. and French drug policy and provide an update on buprenorphine in Baltimore